Inside Precision Medicine February 10, 2025
The use of artificial intelligence (AI) is burgeoning in the drug discovery space as pharma and biotech companies battle to reduce research costs. These five AI players aim to crack the code.
Computing speeds have exponentially improved over the past few decades and labs worldwide are increasingly equipped with tools such as DNA sequencing and genetic engineering. Conversely, the years-long drug development process is becoming slower and more expensive as financial risks grow, the standard of care improves, and regulations become tighter.
AI has swept through the industry as excitement builds around its potential to predict which drug compounds are most likely to fail and succeed. Much of this excitement involves growing numbers of pharmaceutical companies harnessing third-party AI and...
Today's Sponsors
Today's Sponsor